Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

NE October 28, 2025

Noble Corporation Q3 2025 Earnings Call - Backlog and dividend intact as deepwater heads for an H1 2026 trough before a late‑2026 recovery

Noble delivered a solid operational quarter and a $7 billion backlog, but management is explicit: expect a trough in earnings and cash flow in the first half of 2026 before market tightening drives a ...

  • Q3 adjusted EBITDA was $254 million and adjusted EBITDA margin was 32%.
  • Q3 free cash flow was $139 million, excluding $87 million of disposal proceeds from asset sales.
  • Total backlog stood at approximately $7.0 billion as of October 27, including about $2.4 billion slated to convert in 2026 and $1.9 billion in 2027.
  • +12 more takeaways
DHI October 28, 2025

D. R. Horton Fourth Quarter Fiscal 2025 Earnings Call - Holds ~20% Home Sales Gross Margin, Returns $4.8B to Shareholders While Managing Inventory

D. R. Horton closed fiscal 2025 with solid profitability and a defensive playbook. Q4 consolidated pretax income was $1.2 billion on $9.7 billion of revenue, and full year pretax income totaled $4.7 b...

  • Q4 consolidated pretax income was $1.2 billion on $9.7 billion of revenue, and full year consolidated pretax income was $4.7 billion with a 13.8% pretax margin.
  • Home sales gross margin in Q4 was 20.0%, down 180 basis points sequentially, with 110 basis points from higher incentives and 60 basis points from unusually large litigation settlements.
  • Management says the 60 basis point litigation impact is nonrecurring, and Q4 pro forma for litigation would have been roughly 20.6%.
  • +13 more takeaways
AMTB October 28, 2025

Amerant Bancorp Third Quarter 2025 Earnings Call - Asset quality surge forces higher provisions and accelerated NPL remediation

Amerant reported a quarter dominated by credit remediation, not growth. Nonperforming assets jumped to $140 million, or 1.3% of assets, driven by downgrades after a concentrated round of annual and co...

  • Asset quality dominated the quarter: nonperforming assets rose to $140 million, up from $98 million last quarter, equal to 1.3% of total assets.
  • Management completed an intensive review covering roughly $3.5 billion of loans through annual, limited and covenant tests, which drove multiple downgrades and higher specific reserves.
  • Provision for credit losses was $14.6 million in 3Q, comprised of $7.8 million in additional specific reserves, $8.9 million to cover charge offs, offset in part by releases and recoveries.
  • +12 more takeaways
CHKP October 28, 2025

Check Point Software Technologies Q3 2025 Earnings Call - 20% Calculated Billings Growth Signals New Growth Trajectory Fueled by AI Security Deals

Check Point delivered a punchy quarter, driven not by hype but by cashing in on demand across its portfolio. Calculated billings jumped 20% year over year, revenues beat guidance at $678 million, and ...

  • Calculated billings surged 20% year over year to $672 million, a clear growth inflection compared with recent history.
  • Revenue for the quarter was $678 million, up 7% year over year and $6 million above the guidance midpoint.
  • Non-GAAP EPS was $3.94, but that includes a one-time tax benefit of $1.47 per share; excluding the benefit EPS exceeded the midpoint by roughly $0.02.
  • +13 more takeaways
UPS October 28, 2025

UPS Third Quarter 2025 Earnings Call - Amazon Glide Down On Track, Network Reconfig Drives Margin Despite Volume Drop

UPS reported a mixed but controlled quarter, delivering $21.4 billion in revenue, $2.1 billion in operating profit, and a 10% consolidated operating margin while executing the largest network reconfig...

  • Consolidated Q3 revenue $21.4 billion, operating profit $2.1 billion, operating margin 10%, diluted EPS $1.74.
  • GAAP included a net charge of $164 million, reflecting $250 million in transformation costs partially offset by an $86 million tax valuation allowance reversal.
  • U.S. average daily volume declined 12.3% year over year, driven primarily by an Amazon glide down, with Amazon volume down 21.2% in Q3.
  • +14 more takeaways
RGEN October 28, 2025

Repligen Corporation Q3 2025 Earnings Call - 18% Organic Growth, Analytics Surge, Orders Up Six Straight Quarters

Repligen posted a strong Q3 with revenue of $189 million, a 22% reported increase and 18% organic non-COVID growth. Every product franchise grew double digits, led by a standout analytics business tha...

  • Q3 revenue $189 million, reported +22% year over year, organic non-COVID growth +18%
  • Every franchise grew double digits in Q3, signaling broad-based demand rather than a single-product surge
  • Process Analytics led expansion with >50% growth, helped by SoloVPE Plus and $3M from 908 Devices bioprocessing assets
  • +13 more takeaways
AMT October 28, 2025

American Tower Corporation Q3 2025 Earnings Call - Raised 2025 Guidance as CoreSite and Services Drive AFFO Upside

American Tower reported a strong Q3 2025, beating on key metrics and raising full-year guidance after a quarter of robust leasing, near-record services, and breakout data center performance at CoreSit...

  • Company raised full-year 2025 guidance across property revenue, adjusted EBITDA, attributable AFFO, and AFFO per share after a stronger-than-expected quarter.
  • Total revenue grew nearly 8% year over year; consolidated property revenue grew roughly 6% year over year.
  • Adjusted EBITDA grew about 8% year over year, with approximately 20 basis points of cash margin expansion since prior year.
  • +12 more takeaways
NEO October 28, 2025

NeoGenomics Q3 2025 Earnings Call - Record Clinical Growth and Radar ST MRD Cleared for Broad Clinical Launch

NeoGenomics delivered another quarter of record clinical volumes and double digit revenue growth, driven by strong NGS adoption, salesforce expansion in the community oncology channel, and the Pathlin...

  • Total revenue for Q3 2025 was $188 million, up 12% year over year, driven by record clinical volumes.
  • Clinical revenue grew strongly, up 15% on a same‑store basis excluding Pathline; total test volumes increased about 15% in Q3.
  • NGS revenue grew 24% year over year in the quarter, accounting for roughly one third of clinical revenue year to date, signaling meaningful share gains.
  • +13 more takeaways
ZBRA October 28, 2025

Zebra Technologies Q3 2025 Earnings Call - Beat Outlook; Elo and Tariff Mitigation Recenter Growth

Zebra beat its Q3 guide, delivering $1.3 billion in sales, margin improvement and double-digit EPS growth, while leaning on pricing, supply chain fixes and M&A to blunt tariff pain. Management framed ...

  • Q3 results topped guidance: sales $1.3 billion, up 5% year on year on a constant currency basis, adjusted EBITDA margin 21.6% (up 20 bps), non-GAAP EPS $3.88, up 11% y/y.
  • Company reported segment-level growth of Enterprise Visibility and Mobility (EVM) +2% and Asset Intelligence and Tracking (AIT) +11%, with historical results recast for two new forthcoming segments: Connected Frontline, and Asset Visibility and Automation.
  • Regional performance was mixed: Asia Pacific +23% (led by Australia, New Zealand, India and Japan), Latin America +8%, North America +6% (strength in mobile computing and RFID; Canada softer), EMEA down 3% with Germany and some manufacturing markets weak.
  • +12 more takeaways
ATI October 28, 2025

ATI Q3 2025 Earnings Call - Aerospace & Defense Surge to 70% of Revenue, Driving Margin Expansion and Raised Guidance

ATI closed Q3 2025 by beating estimates, accelerating its pivot into aerospace and defense, and raising full year targets. Revenue rose 7% year over year to above $1.1 billion, adjusted EPS was $0.85,...

  • Q3 revenue grew 7% year over year, topping $1.1 billion and beating expectations.
  • Adjusted EPS was $0.85, $0.10 above the high end of prior guidance.
  • Adjusted EBITDA totaled $225 million, which includes about $10 million from the sale of oil and gas rights; $215 million excluding that sale.
  • +13 more takeaways